Press release
Antibody Drug Conjugates Market 2019 Present Industry Insights with Key Growth Trends Led by CERBIOS - PHARMA SA, F. Hoffmann-La Roche, Lonza, Merck KGaA, Novasep, Pfizer, Piramal Group
Antibody Drug Conjugates Market to 2027 - Global Analysis and Forecasts By Technology (Cleavable Linker, Non-cleavable Linker); Application (Blood Cancer, Brain Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer) and GeographyAntibody Drug Conjugates market is anticipated to grow in the forecast, owing to rising prevalence of cancer cases across the globe and growing geriatric population base. In addition, the presence of strong product offering in the pipeline by the players is expected to offer significant growth opportunities in the market during the forecast period.
Antibody Drug Conjugates (ADCs) are specifically to deliver cytotoxins to cancer cells with capacity to treat both solid tumors and hematologic cancers. With the help of a linker, an ADC is able to target and bind to cell-surface proteins found on cancer cells and release its cell-killing drugs. This property helps ADCs to selectively kill cancer cells and limit side effects for patients.
Get Sample Report at https://www.theinsightpartners.com/sample/TIPRE00003494?sk
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antibody drug conjugates market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibody drug conjugates market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report also includes the profiles of key antibody drug conjugates market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-AbbVie Inc.
-Baxter Healthcare Corporation
-CERBIOS - PHARMA SA
-F. Hoffmann-La Roche Ltd
-Lonza
-Merck KGaA
-Novasep
-Pfizer Inc.
-Piramal Group
-Syngene
The report analyzes factors affecting antibody drug conjugates market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibody drug conjugates market in these regions.
Browse Complete Report at https://www.theinsightpartners.com/reports/antibody-drug-conjugates-market?sk
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Drug Conjugates Market - By Technology
1.3.2 Antibody Drug Conjugates Market - By Application
1.3.3 Antibody Drug Conjugates Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODY DRUG CONJUGATES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODY DRUG CONJUGATES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
Buy this Report at https://www.theinsightpartners.com/inquiry/TIPRE00003494?sk
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Drug Conjugates Market 2019 Present Industry Insights with Key Growth Trends Led by CERBIOS - PHARMA SA, F. Hoffmann-La Roche, Lonza, Merck KGaA, Novasep, Pfizer, Piramal Group here
News-ID: 1757925 • Views: …
More Releases from The Insight Partners
The Complete Guide to Hydrogen Fuel Cell Stacks
The fuel cell stack is the heart of the fuel cell power system. It produces electricity in the form of direct current (DC) from the electrochemical reactions that occur in fuel cells. A single fuel cell produces less than 1V, which is not sufficient for most applications. Therefore, individual fuel cells are usually combined in series to form a fuel cell stack.
Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00029545/?utm_source=OpenPR&utm_medium=10413
The List Of Companies
Advent…
Branded Generics Market Size, Growth, Share, Regional Prospects, Opportunities a …
The Branded Generics Market research report by The Insight Partners includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the Branded Generics Market growth.
The…

Permeate Market Size, Analysis, Demand, Segments, Industry Growth and Recent Tre …
Permeate Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
An exclusive Permeate Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the…

Solar Shingle Market Analysis, Development Trends, Driving Forces, Opportunities …
The Solar Shingle Market research report by The Insight Partners includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the Solar Shingle Market growth.
The…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…